Tcr2 Therapeutics Inc (TCRR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TCRR | ECOR | CSBR | ||
| Company | Tcr2 Therapeutics Inc | Electrocore Inc | Champions Oncolog | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.5800 | 10.00 | 4.37 | ||
| High | 1.6300 | 11.50 | 4.65 | ||
| Low | 1.4800 | 10.00 | 4.30 | ||
| Last | 1.4800 | 11.21 | 4.55 | ||
| Change | -0.0900 | +1.29 | +0.28 | ||
| % Change | -5.73% | +13.00% | +6.56% | ||
| Volume | 3,913,300 | 110,200 | 9,200 | ||
| 20-Day Average Volume | 474,175 | 147,780 | 10,945 | ||
| Previous Close | 1.5700 | 9.92 | 4.27 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | No | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 1.8315 | 11.75 | 4.30 | ||
| 20-Day Raw Stochastic | 0.00% | 35.03% | 84.21% | ||
| 20-Day Relative Strength | 35.83% | 54.67% | 52.91% | ||
| Weighted Alpha | -29.20 | +80.30 | -15.21 | ||
| Today's Opinion | 8% Buy | 72% Buy | 64% Sell | ||
| Previous Opinion | 24% Buy | 72% Buy | 88% Sell | ||
| Last Month's Opinion | 56% Buy | 88% Buy | 80% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -14.45% since 05/23/23 | +2.47% since 11/15/24 | +1.11% since 11/15/24 | ||
| Low | 1.4800 on 05/31/23 | 9.60 on 11/20/24 | 4.26 on 11/20/24 | ||
| High | 1.7800 on 05/24/23 | 11.51 on 11/18/24 | 4.70 on 11/19/24 | ||
| 1-Month | |||||
| %Chg | -16.15% since 04/28/23 | +12.21% since 10/22/24 | +4.12% since 10/22/24 | ||
| Low | 1.4800 on 05/31/23 | 9.35 on 10/23/24 | 3.75 on 10/31/24 | ||
| High | 2.0400 on 05/08/23 | 14.20 on 11/13/24 | 4.70 on 11/19/24 | ||
| 3-Month | |||||
| %Chg | +18.40% since 02/28/23 | +86.83% since 08/22/24 | +3.20% since 08/22/24 | ||
| Low | 1.1521 on 03/03/23 | 5.80 on 09/09/24 | 3.60 on 09/10/24 | ||
| High | 2.0400 on 05/08/23 | 14.20 on 11/13/24 | 5.45 on 09/16/24 | ||
| 6-Month | |||||
| %Chg | +13.85% since 11/28/22 | +60.20% since 05/22/24 | -2.78% since 05/22/24 | ||
| Low | 0.8210 on 12/23/22 | 5.51 on 08/05/24 | 3.60 on 09/10/24 | ||
| High | 2.0400 on 05/08/23 | 14.20 on 11/13/24 | 5.45 on 09/16/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 58,108 | 65,022 | 58,046 | ||
| Shares Outstanding, K | 39,262 | 6,555 | 13,594 | ||
| Annual Sales | 0 | 16,030,000 | 50,160,000 | ||
| Annual Net Income | -151,820,000 | -18,830,000 | -7,280,000 | ||
| Last Quarter Sales | 0 | 6,550,000 | 14,060,000 | ||
| Last Quarter Net Income | -40,400,000 | -2,500,000 | 1,310,000 | ||
| 60-Month Beta | 1.94 | 0.56 | 0.50 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.03 on 05/11/23 | -0.31 on 11/13/24 | 0.09 on 09/11/24 | ||
| Latest Earnings Date | 05/11/23 | 11/13/24 | 12/10/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||